-
1
-
-
84896459209
-
-
edited by B. W. Stewart and C. P. Wild (IARC Nonserial Publication, Lyon)
-
B. W. Stewart and C. P. Wild, World Cancer Report 2014, edited by B. W. Stewart and C. P. Wild (IARC Nonserial Publication, Lyon, 2014), p. 630.
-
(2014)
World Cancer Report 2014
, pp. 630
-
-
Stewart, B.W.1
Wild, C.P.2
-
2
-
-
47749088624
-
Comparative studies of 177Lu-EDTMP and 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis
-
S. Chakraborty, T. Das, H. D. Sarma, M. Venkatesh, and S. Banerjee, " Comparative studies of 177Lu-EDTMP and 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis," Appl. Radiat. Isot. 66 (9), 1196-1205 (2008). 10.1016/j.apradiso.2008.02.061
-
(2008)
Appl. Radiat. Isot.
, vol.66
, Issue.9
, pp. 1196-1205
-
-
Chakraborty, S.1
Das, T.2
Sarma, H.D.3
Venkatesh, M.4
Banerjee, S.5
-
3
-
-
1842583328
-
Radionuclide therapy with bone seeking radionuclides in palliation of painful bone metastases
-
C. L. Maini, R. Sciuto, L. Romano, and S. Bergomi, " Radionuclide therapy with bone seeking radionuclides in palliation of painful bone metastases," J. Exp. Clin. Cancer Res. 22 (4 Suppl.), 71-74 (2003), available at: http://www.ncbi.nlm.nih.gov/pubmed/16767910.
-
(2003)
J. Exp. Clin. Cancer Res.
, vol.22
, Issue.4
, pp. 71-74
-
-
Maini, C.L.1
Sciuto, R.2
Romano, L.3
Bergomi, S.4
-
4
-
-
84897769430
-
Minimally invasive local treatments for bone and pulmonary metastases
-
M. Bedi, D. M. King, and S. Tutton, " Minimally invasive local treatments for bone and pulmonary metastases," Minimally Invasive Surg. 2014, 1-9 (2014). 10.1155/2014/719394
-
(2014)
Minimally Invasive Surg.
, vol.2014
, pp. 1-9
-
-
Bedi, M.1
King, D.M.2
Tutton, S.3
-
5
-
-
14844361408
-
Bone-seeking radionuclides for therapy
-
V. J. Lewington, " Bone-seeking radionuclides for therapy," J. Nucl. Med. 46 (Suppl. 1), 38S-47S (2005), available at: http://www.ncbi.nlm.nih.gov/pubmed/16767910.
-
(2005)
J. Nucl. Med.
, vol.46
, pp. 38S-47S
-
-
Lewington, V.J.1
-
6
-
-
84897939554
-
Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride
-
N. Pandit-Taskar, S. M. Larson, and J. A. Carrasquillo, " Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride," J. Nucl. Med. 55 (2), 268-274 (2014). 10.2967/jnumed.112.112482
-
(2014)
J. Nucl. Med.
, vol.55
, Issue.2
, pp. 268-274
-
-
Pandit-Taskar, N.1
Larson, S.M.2
Carrasquillo, J.A.3
-
7
-
-
0029972407
-
Dosage and Response in radiopharmaceutical therapy of painful osseous metastases dosage and response in radiopharmaceutical therapy of
-
E. B. Silberstein and S. M. Drive, " Dosage and Response in radiopharmaceutical therapy of painful osseous metastases dosage and response in radiopharmaceutical therapy of," J. Nucl. Med. 37, 249-252 (1996).
-
(1996)
J. Nucl. Med.
, vol.37
, pp. 249-252
-
-
Silberstein, E.B.1
Drive, S.M.2
-
8
-
-
0042009841
-
Production logistics of 177Lu for radionuclide therapy
-
M. R. A. Pillai, S. Chakraborty, T. Das, M. Venkatesh, and N. Ramamoorthy, " Production logistics of 177Lu for radionuclide therapy," Appl. Radiat. Isot. 59 (2-3), 109-118 (2003). 10.1016/S0969-8043(03)00158-1
-
(2003)
Appl. Radiat. Isot.
, vol.59
, Issue.2-3
, pp. 109-118
-
-
Pillai, M.R.A.1
Chakraborty, S.2
Das, T.3
Venkatesh, M.4
Ramamoorthy, N.5
-
9
-
-
77953694582
-
Production of 177 Lu and formulation of ethylene diamine tetramethylene phosphonate (EDTMP) kits as a bone-seeking radiopharmaceutical
-
F. J. Daha et al., " Production of 177 Lu and formulation of ethylene diamine tetramethylene phosphonate (EDTMP) kits as a bone-seeking radiopharmaceutical," Iran. J. Radiat. Res. 7 (4), 229-234 (2010).
-
(2010)
Iran. J. Radiat. Res.
, vol.7
, Issue.4
, pp. 229-234
-
-
Daha, F.J.1
-
10
-
-
80052679690
-
In vitro study on apoptosis induced by strontium-89 in human breast carcinoma cell line
-
C. Wang, J. Wang, H. Jiang, M. Zhu, B. Chen, and W. Bao, " In vitro study on apoptosis induced by strontium-89 in human breast carcinoma cell line," J. Biomed. Biotechnol. 2011, 541487. 10.1155/2011/541487
-
J. Biomed. Biotechnol.
, vol.2011
, pp. 541487
-
-
Wang, C.1
Wang, J.2
Jiang, H.3
Zhu, M.4
Chen, B.5
Bao, W.6
-
11
-
-
84872507131
-
Radium-223 chloride: A potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease
-
M. R. Harrison, T. Z. Wong, A. J. Armstrong, and D. J. George, " Radium-223 chloride: A potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease," Cancer Manage. Res. 5, 1-14 (2013). 10.2147/CMAR.S25537
-
(2013)
Cancer Manage. Res.
, vol.5
, pp. 1-14
-
-
Harrison, M.R.1
Wong, T.Z.2
Armstrong, A.J.3
George, D.J.4
-
12
-
-
77950501011
-
(99m)Tc Auger electrons for targeted tumour therapy: A review
-
A. A. S. Tavares and J. M. R. S. Tavares, " (99m)Tc Auger electrons for targeted tumour therapy: A review," Int. J. Radiat. Biol. 86 (4), 261-270 (2010). 10.3109/09553000903564083
-
(2010)
Int. J. Radiat. Biol.
, vol.86
, Issue.4
, pp. 261-270
-
-
Tavares, A.A.S.1
Tavares, J.M.R.S.2
-
13
-
-
0037315930
-
Targeting of osseous sites with alpha-emitting 223Ra: Comparison witn the beta-emitter 89Sr in Mice
-
G. Henriksen, D. R. Fisher, J. C. Roeske, Ø. S. Bruland, and R. H. Larsen, " Targeting of osseous sites with alpha-emitting 223Ra: comparison witn the beta-emitter 89Sr in Mice," J. Nucl. Med. 44 (2), 252-259 (2003).
-
(2003)
J. Nucl. Med.
, vol.44
, Issue.2
, pp. 252-259
-
-
Henriksen, G.1
Fisher, D.R.2
Roeske, J.C.3
Bruland Ø, S.4
Larsen, R.H.5
-
14
-
-
0012725753
-
Therapeutic radiopharmaceuticals
-
W. A. Volkert and T. J. Hoffman, " Therapeutic radiopharmaceuticals," Chem. Rev. 99 (9), 2269-2292 (1999), available at: http://www.ncbi.nlm.nih.gov/pubmed/11749482. 10.1021/cr9804386
-
(1999)
Chem. Rev.
, vol.99
, Issue.9
, pp. 2269-2292
-
-
Volkert, W.A.1
Hoffman, T.J.2
-
15
-
-
84908277034
-
Radiopharmaceutical therapy
-
T. Ramdahl, G. D. Flux, and G. Sgouros, " radiopharmaceutical therapy," Phys. Med. Biol. 57 (10), 3207-3222 (2013).
-
(2013)
Phys. Med. Biol.
, vol.57
, Issue.10
, pp. 3207-3222
-
-
Ramdahl, T.1
Flux, G.D.2
Sgouros, G.3
-
16
-
-
84874543674
-
Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases
-
S. Nilsson et al., " Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases," Clin. Genitourin. Cancer 11 (1), 20-26 (2013). 10.1016/j.clgc.2012.07.002
-
(2013)
Clin. Genitourin. Cancer
, vol.11
, Issue.1
, pp. 20-26
-
-
Nilsson, S.1
-
17
-
-
84897135731
-
Rhenium-188 production in hospitals, by w-188/re-188 generator, for easy use in radionuclide therapy
-
M. Argyrou, A. Valassi, M. Andreou, and M. Lyra, " Rhenium-188 production in hospitals, by w-188/re-188 generator, for easy use in radionuclide therapy," Int. J. Mol. Imaging 2013, 1-7 (2013). 10.1155/2013/290750
-
(2013)
Int. J. Mol. Imaging
, vol.2013
, pp. 1-7
-
-
Argyrou, M.1
Valassi, A.2
Andreou, M.3
Lyra, M.4
-
18
-
-
84859476468
-
The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases
-
M. Tomblyn, " The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases," Cancer Control 19 (2), 137-144 (2012), available at: http://www.ncbi.nlm.nih.gov/pubmed/22487976.
-
(2012)
Cancer Control
, vol.19
, Issue.2
, pp. 137-144
-
-
Tomblyn, M.1
-
19
-
-
84860385517
-
Radiopharmaceuticals for cancer therapy
-
N. Sivaprasad and G. Rajagopal, " Radiopharmaceuticals for cancer therapy," Pharma times 44 (04), 26-29 (2012).
-
(2012)
Pharma Times
, vol.44
, Issue.4
, pp. 26-29
-
-
Sivaprasad, N.1
Rajagopal, G.2
-
20
-
-
84864009519
-
A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical
-
J. Simón, R. K. Frank, D. K. Crump, W. D. Erwin, N. T. Ueno, and R. E. Wendt, " A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical," Nucl. Med. Biol. 39 (6), 770-776 (2012). 10.1016/j.nucmedbio.2011.12.015
-
(2012)
Nucl. Med. Biol.
, vol.39
, Issue.6
, pp. 770-776
-
-
Simón, J.1
Frank, R.K.2
Crump, D.K.3
Erwin, W.D.4
Ueno, N.T.5
Wendt, R.E.6
-
21
-
-
84864008854
-
Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation
-
I. A. Abbasi, " Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation," Nucl. Med. Biol. 39 (6), 763-769 (2012). 10.1016/j.nucmedbio.2012.02.001
-
(2012)
Nucl. Med. Biol.
, vol.39
, Issue.6
, pp. 763-769
-
-
Abbasi, I.A.1
-
22
-
-
79958758220
-
Characterization of the [(153)Sm]Sm-EDTMP pharmacokinetics and estimation of radiation absorbed dose on an individual basis
-
L. Vigna et al., " Characterization of the [(153)Sm]Sm-EDTMP pharmacokinetics and estimation of radiation absorbed dose on an individual basis," Phys. Med. 27 (3), 144-152 (2011). 10.1016/j.ejmp.2010.08.001
-
(2011)
Phys. Med.
, vol.27
, Issue.3
, pp. 144-152
-
-
Vigna, L.1
-
23
-
-
84856688093
-
Radioisotope therapy of bone metastases
-
M. Bczyk, " Radioisotope therapy of bone metastases," Nucl. Med. Rev. Cent. East. Eur. 14 (2), 96-104 (2011), available at: http://www.ncbi.nlm.nih.gov/pubmed/22219150. 10.5603/NMR.2011.00023
-
(2011)
Nucl. Med. Rev. Cent. East. Eur.
, vol.14
, Issue.2
, pp. 96-104
-
-
Bczyk, M.1
-
24
-
-
79954415168
-
Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation
-
I. A. Abbasi, " Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation," Nucl. Med. Biol. 38 (3), 417-425 (2011). 10.1016/j.nucmedbio.2010.09.013
-
(2011)
Nucl. Med. Biol.
, vol.38
, Issue.3
, pp. 417-425
-
-
Abbasi, I.A.1
-
25
-
-
76949107894
-
Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent
-
D. Máthé et al., " Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent," Nucl. Med. Biol. 37 (2), 215-226 (2010). 10.1016/j.nucmedbio.2009.09.004
-
(2010)
Nucl. Med. Biol.
, vol.37
, Issue.2
, pp. 215-226
-
-
Máthé, D.1
-
26
-
-
67349116345
-
(170)Tm-EDTMP: A potential cost-effective alternative to (89)SrCl(2) for bone pain palliation
-
T. Das et al., " (170)Tm-EDTMP: A potential cost-effective alternative to (89)SrCl(2) for bone pain palliation," Nucl. Med. Biol. 36 (5), 561-568 (2009). 10.1016/j.nucmedbio.2009.02.002
-
(2009)
Nucl. Med. Biol.
, vol.36
, Issue.5
, pp. 561-568
-
-
Das, T.1
-
27
-
-
62549141442
-
Comparison of systemic toxicities of 177Lu-DOTMP and 153Sm-EDTMP administered intravenously at equivalent skeletal doses to normal dogs
-
J. N. Bryan et al., " Comparison of systemic toxicities of 177Lu-DOTMP and 153Sm-EDTMP administered intravenously at equivalent skeletal doses to normal dogs," J. Nucl. Med. Technol. 37 (1), 45-52 (2009). 10.2967/jnmt.108.054700
-
(2009)
J. Nucl. Med. Technol.
, vol.37
, Issue.1
, pp. 45-52
-
-
Bryan, J.N.1
-
28
-
-
34347244905
-
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: A randomised, multicentre, placebo-controlled phase II study
-
S. Nilsson et al., " Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: A randomised, multicentre, placebo-controlled phase II study," Lancet Oncol. 8 (7), 587-594 (2007). 10.1016/S1470-2045(07)70147-X
-
(2007)
Lancet Oncol.
, vol.8
, Issue.7
, pp. 587-594
-
-
Nilsson, S.1
-
29
-
-
18044378963
-
Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study
-
S. Nilsson et al., " Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study," J. Pain Symptom Manage. 29 (4), 352-357 (2005). 10.1016/j.jpainsymman.2004.07.008
-
(2005)
J. Pain Symptom Manage.
, vol.29
, Issue.4
, pp. 352-357
-
-
Nilsson, S.1
-
30
-
-
20644447798
-
First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases
-
S. Nilsson et al., " First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases," Clin. Cancer Res. 11 (12), 4451-4459 (2005). 10.1158/1078-0432.CCR-04-2244
-
(2005)
Clin. Cancer Res.
, vol.11
, Issue.12
, pp. 4451-4459
-
-
Nilsson, S.1
-
31
-
-
29144536598
-
Radionuclides used for therapy and suggestion for new candidates
-
M. Neves, A. Kling, and A. Oliveira, " Radionuclides used for therapy and suggestion for new candidates," J. Radioanal. Nucl. Chem. 266 (3), 377-384 (2005). 10.1007/s10967-005-0920-5
-
(2005)
J. Radioanal. Nucl. Chem.
, vol.266
, Issue.3
, pp. 377-384
-
-
Neves, M.1
Kling, A.2
Oliveira, A.3
-
32
-
-
33746883985
-
Overview of samarium sm 153 lexidronam in the treatment of painful metastatic bone disease
-
O. Sartor, " Overview of samarium sm 153 lexidronam in the treatment of painful metastatic bone disease," Rev. Urol. 6 (10 Suppl.), S3-S12 (2004), available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1472939&tool=pmcentrez&rendertype=abstract.
-
(2004)
Rev. Urol.
, vol.6
, Issue.10
, pp. S3-S12
-
-
Sartor, O.1
-
33
-
-
34547658355
-
Table of radionuclides
-
M. Bé et al., " Table of radionuclides," Bur. Int. Poids. Mes. 1,2,3,6, 1-6 (2008).
-
(2008)
Bur. Int. Poids. Mes.
, vol.1236
, pp. 1-6
-
-
Bé, M.1
-
34
-
-
0034110727
-
Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions
-
L. G. Bouchet, W. E. Bolch, S. M. Goddu, R. W. Howell, and D. V. Rao, " Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions," J. Nucl. Med. 41 (4), 682-687 (2000), available at: http://www.ncbi.nlm.nih.gov/pubmed/10768569.
-
(2000)
J. Nucl. Med.
, vol.41
, Issue.4
, pp. 682-687
-
-
Bouchet, L.G.1
Bolch, W.E.2
Goddu, S.M.3
Howell, R.W.4
Rao, D.V.5
-
35
-
-
84863093187
-
Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases
-
J. Goyal and E. S. Antonarakis, " Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases," Cancer Lett. 323 (2), 135-146 (2012). 10.1016/j.canlet.2012.04.001
-
(2012)
Cancer Lett.
, vol.323
, Issue.2
, pp. 135-146
-
-
Goyal, J.1
Antonarakis, E.S.2
-
36
-
-
0031929619
-
Treatment of metastatic bone pain with tin-117m stannic diethylenetriaminepentaacetic acid: A phase I/II clinical study
-
S. C. Srivastava et al., " Treatment of metastatic bone pain with tin-117m stannic diethylenetriaminepentaacetic acid: A phase I/II clinical study," Clin. Cancer Res. 4 (1), 61-68 (1998), available at: http://www.ncbi.nlm.nih.gov/pubmed/9516953.
-
(1998)
Clin. Cancer Res.
, vol.4
, Issue.1
, pp. 61-68
-
-
Srivastava, S.C.1
-
37
-
-
22444444683
-
Radiopharmaceuticals for the palliation of painful bone metastases - A systematic review
-
Therapeutic Radiopharmaceutical Guidelines Grouof Cancer Care Ontario's Program in Evidence-based Care
-
G. Bauman, M. Charette, R. Reid, J. Sathya, C. Ontario, and Therapeutic Radiopharmaceutical Guidelines Group of Cancer Care Ontario's Program in Evidence-based Care, " Radiopharmaceuticals for the palliation of painful bone metastases-A systematic review," Radiother. Oncol. 75, 1-13 (2005). 10.1016/j.radonc.2005.03.003
-
(2005)
Radiother. Oncol.
, vol.75
, pp. 1-13
-
-
Bauman, G.1
Charette, M.2
Reid, R.3
Sathya, J.4
Ontario, C.5
-
38
-
-
0024313271
-
Yttrium-90-EDTMP: A radiotherapeutic agent in the treatment of leukaemias
-
A. A. Keeling, A. T. M. Vaughan, and R. P. Beaney, " Yttrium-90-EDTMP: A radiotherapeutic agent in the treatment of leukaemias," Br. J. Cancer 60, 74-78 (1989). 10.1038/bjc.1989.223
-
(1989)
Br. J. Cancer
, vol.60
, pp. 74-78
-
-
Keeling, A.A.1
Vaughan, A.T.M.2
Beaney, R.P.3
-
39
-
-
84883300098
-
Advances in anticancer radiopharmaceuticals
-
M. R. Jackson, N. Falzone, and K. A. Vallis, " Advances in anticancer radiopharmaceuticals," Clin. Oncol. (R. Coll. Radiol.) 25 (10), 604-609 (2013). 10.1016/j.clon.2013.06.004
-
(2013)
Clin. Oncol. (R. Coll. Radiol.)
, vol.25
, Issue.10
, pp. 604-609
-
-
Jackson, M.R.1
Falzone, N.2
Vallis, K.A.3
-
40
-
-
2442448170
-
A fast Monte Carlo algorithm to simulate the spectrum of DNA damages formed by ionizing radiation
-
V. A. Semenenko and R. D. Stewart, " A fast Monte Carlo algorithm to simulate the spectrum of DNA damages formed by ionizing radiation," Radiat. Res. 161 (4), 451-457 (2004), available at: http://www.ncbi.nlm.nih.gov/pubmed/15038766. 10.1667/RR3140
-
(2004)
Radiat. Res.
, vol.161
, Issue.4
, pp. 451-457
-
-
Semenenko, V.A.1
Stewart, R.D.2
-
41
-
-
42949175799
-
Combined use of Monte Carlo DNA damage simulations and deterministic repair models to examine putative mechanisms of cell killing
-
D. J. Carlson, R. D. Stewart, V. A. Semenenko, and G. A. Sandison, " Combined use of Monte Carlo DNA damage simulations and deterministic repair models to examine putative mechanisms of cell killing," Radiat. Res. 169 (4), 447-459 (2008). 10.1667/RR1046.1
-
(2008)
Radiat. Res.
, vol.169
, Issue.4
, pp. 447-459
-
-
Carlson, D.J.1
Stewart, R.D.2
Semenenko, V.A.3
Sandison, G.A.4
-
42
-
-
0031895520
-
Track structure in radiation biology: Theory and applications
-
H. Nikjoo, S. Uehara, W. E. Wilson, M. Hoshi, and D. T. Goodhead, " Track structure in radiation biology: Theory and applications," Int. J. Radiat. Biol. 73 (4), 355-364 (1998), available at: http://www.ncbi.nlm.nih.gov/pubmed/9587072. 10.1080/095530098142176
-
(1998)
Int. J. Radiat. Biol.
, vol.73
, Issue.4
, pp. 355-364
-
-
Nikjoo, H.1
Uehara, S.2
Wilson, W.E.3
Hoshi, M.4
Goodhead, D.T.5
-
43
-
-
37249013401
-
Radiation track and DNA damage
-
H. Nikjoo, " Radiation track and DNA damage," Iran. J. Radiat. Res. 1 (1), 3-16 (2003).
-
(2003)
Iran. J. Radiat. Res.
, vol.1
, Issue.1
, pp. 3-16
-
-
Nikjoo, H.1
-
44
-
-
33645299354
-
Fast Monte Carlo simulation of DNA damage formed by electrons and light ions
-
V. A. Semenenko and R. D. Stewart, " Fast Monte Carlo simulation of DNA damage formed by electrons and light ions," Phys. Med. Biol. 51 (7), 1693-1706 (2006). 10.1088/0031-9155/51/7/004
-
(2006)
Phys. Med. Biol.
, vol.51
, Issue.7
, pp. 1693-1706
-
-
Semenenko, V.A.1
Stewart, R.D.2
-
45
-
-
22944448079
-
Monte Carlo simulation of base and nucleotide excision repair of clustered DNA damage sites. II. Comparisons of model predictions to measured data
-
V. A. Semenenko and R. D. Stewart, " Monte Carlo simulation of base and nucleotide excision repair of clustered DNA damage sites. II. Comparisons of model predictions to measured data," Radiat. Res. 164 (2), 194-201 (2005). 10.1667/RR3414
-
(2005)
Radiat. Res.
, vol.164
, Issue.2
, pp. 194-201
-
-
Semenenko, V.A.1
Stewart, R.D.2
-
46
-
-
0030796648
-
Review the link between low -LET dose-response relations and the underlying kinetics of dam age production/repair/m isrepair
-
R. K. S. Sach, P. H. A. H. N. Feld, and D. J. B. Er, " Review the link between low -LET dose-response relations and the underlying kinetics of dam age production/repair/m isrepair," Int. J. Radiat. Biol. 72 (4), 351-374 (1997). 10.1080/095530097143149
-
(1997)
Int. J. Radiat. Biol.
, vol.72
, Issue.4
, pp. 351-374
-
-
Sach, R.K.S.1
Feld, P.H.A.H.N.2
Er, D.J.B.3
-
47
-
-
0037037177
-
Equivalence of the linear-quadratic and two-lesion kinetic models
-
M. Guerrero, R. D. Stewart, J. Z. Wang, and X. A. Li, " Equivalence of the linear-quadratic and two-lesion kinetic models," Phys. Med. Biol. 47 (17), 3197-3209 (2002), available at: http://www.ncbi.nlm.nih.gov/pubmed/12361218. 10.1088/0031-9155/47/17/310
-
(2002)
Phys. Med. Biol.
, vol.47
, Issue.17
, pp. 3197-3209
-
-
Guerrero, M.1
Stewart, R.D.2
Wang, J.Z.3
Li, X.A.4
-
48
-
-
84908277337
-
-
See supplementary material at E-MPHYA6-41-007411 for the summary of the key clinical outcomes of different radiotracers currently used in the clinical setting or under research for palliative treatment of bone metastases
-
See supplementary material at http://dx.doi.org/10.1118/1.4897240 E-MPHYA6-41-007411 for the summary of the key clinical outcomes of different radiotracers currently used in the clinical setting or under research for palliative treatment of bone metastases.
-
-
-
-
49
-
-
0029045402
-
Implication of cell kinetic changes during the progression of human prostatic cancer
-
R. R. Berges et al., " Implication of cell kinetic changes during the progression of human prostatic cancer," Clin. Cancer Res. 1 (5), 473-480 (1995), available at: http://www.ncbi.nlm.nih.gov/pubmed/9816006.
-
(1995)
Clin. Cancer Res.
, vol.1
, Issue.5
, pp. 473-480
-
-
Berges, R.R.1
-
50
-
-
77954697510
-
Evaluating [sup 99m]Tc Auger electrons for targeted tumor radiotherapy by computational methods
-
A. A. S. Tavares and J. M. R. S. Tavares, " Evaluating [sup 99m]Tc Auger electrons for targeted tumor radiotherapy by computational methods," Med. Phys. 37 (7), 3551-3559 (2010). 10.1118/1.3451117
-
(2010)
Med. Phys.
, vol.37
, Issue.7
, pp. 3551-3559
-
-
Tavares, A.A.S.1
Tavares, J.M.R.S.2
-
51
-
-
22944466104
-
Monte Carlo simulation of base and nucleotide excision repair of clustered DNA damage sites. I. Model properties and predicted trends
-
V. A. Semenenko, R. D. Stewart, and E. J. Ackerman, " Monte Carlo simulation of base and nucleotide excision repair of clustered DNA damage sites. I. Model properties and predicted trends," Radiat. Res. 164 (2), 180-193 (2005). 10.1667/RR3402
-
(2005)
Radiat. Res.
, vol.164
, Issue.2
, pp. 180-193
-
-
Semenenko, V.A.1
Stewart, R.D.2
Ackerman, E.J.3
-
52
-
-
0034807357
-
Two-lesion kinetic model of double-strand break rejoining and cell killing
-
R. D. Stewart, " Two-lesion kinetic model of double-strand break rejoining and cell killing," Radiat. Res. 156 (4), 365-378 (2001), available at: http://www.ncbi.nlm.nih.gov/pubmed/11554848. 10.1667/0033-7587(2001)156[0365:TLKMOD]2.0.CO;2
-
(2001)
Radiat. Res.
, vol.156
, Issue.4
, pp. 365-378
-
-
Stewart, R.D.1
|